Grants

  • ADDF-Harrington Scholar Program

    Sponsor: Alzheimer’s Drug Discovery Foundation LOI due date:  April 23rd, 2021, 5:00 PM EDT Full Application due date: July 30th, 2021, 5:00 PM EDT Award: Up to $600,000 over 2 years with dedicated support from a team of industry veterans wit...

    July 30
  • Cycle 1: Alzheimer’s Drug Discovery Foundation

    LOI Due Dates: Cycle 1: May 28, 2021 Cycle 2: October 1, 2021 Full Proposal Deadlines: Cycle 1: July 30, 2021 Cycle 2: December 3, 2021 Drug Development Program The goal of this RFP is to develop therapeutics for Alzheimer’s disease and related...

    July 30
    |Recurring Event (See all)

    One event on December 3, 2021 at 12:00 am

  • Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)

    Sponsor: National Institutes of Health (multiple Institutes) LOI Due Dates: 30 days before deadline Due Date: August 10, 2021, February 9, 2022 Award: Application budgets are not limited but must reflect the actual needs of the proposed project. App...

    August 10
    |Recurring Event (See all)

    One event on February 9, 2022 at 12:00 am

  • NIH R21, R03

    Sponsor: National Institute of Health  DUE DATES:  Cycle 3: October 16, 2020 by 5 PM of local organization time Cycle 1: February 16, 2021 by 5 PM of local organization time Cycle 2: June 16, 2021 by 5 PM of local organization time Biobehavioral an...

    October 16
    |Recurring Event (See all)

    One event on February 16, 2021 at 12:00 am

    One event on October 16, 2021 at 12:00 am

  • Cycle 1: Alzheimer’s Drug Discovery Foundation

    LOI Due Dates: Cycle 1: May 28, 2021 Cycle 2: October 1, 2021 Full Proposal Deadlines: Cycle 1: July 30, 2021 Cycle 2: December 3, 2021 Drug Development Program The goal of this RFP is to develop therapeutics for Alzheimer’s disease and related...

    December 3
    |Recurring Event (See all)

    One event on December 3, 2021 at 12:00 am

  • ANGEL (Advanced Neurotherapeutic Grant of Excellence) Award

    Sponsor: International Rett Syndrome Foundation (IRSF) Due Date: Applications accepted on a rolling basis Award: Up to $600,000 over two years. Grant awards must be comprised of very specific programs that are focused on pre-clinical drug discovery a...

    December 31
  • Rolling Basis: Alzheimer’s Drug Discovery Foundation

    PROPOSALS ACCEPTED ON A ROLLING BASIS ADDF/NIH Supports NIA and NINDS grant proposals in NIH format that were scored but not funded, which fall within our mission and research priorities. Conference Funding Supports scientific conferences that are re...

    December 31
  • Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)

    Sponsor: National Institutes of Health (multiple Institutes) LOI Due Dates: 30 days before deadline Due Date: August 10, 2021, February 9, 2022 Award: Application budgets are not limited but must reflect the actual needs of the proposed project. App...

    February 9, 2022
    |Recurring Event (See all)

    One event on February 9, 2022 at 12:00 am

View All Events